baber/WOPTO huggingface dataset:
Patent ES-499740-A0 (ES)
IPC: A01N47/02
Filed: 1981-02-24
Abstract: N-Phenylpyrazole derivatives of the formula:- <CHEM> (wherein each of R<5> and R<6> represents a C1-C4 alkyl or alkoxy radical, a trifluoromethyl, trifluoromethoxy, nitro, cyano or primary amino radical, or a fluorine, chlorine or bromine atom, each of R<7>, R<8> and R<9> represents a hydrogen atom, a C1-C4 alkyl or alkoxy radical, a trifluoromethyl, trifluoromethoxy, nitro, cyano or primary amino radical or a fluorine, chlorine or bromine atom, or R<5>, R<7>, R<8> and R<9> each represents a hydrogen atom and R<6> represents a trifluoromethoxy or trifluromethyl radical, and R<1><0> represents a cyano radical or substituted carbamoyl radical -CONHR<1><1>, wherein R<1><1> represents a methyl or ethyl radical) have been found to possess useful herbicidal properties. All such N-phenylpyrazole derivatives with the exception of 5-amino-4-cyano-1-(2,4-dichlorophenyl)pyrazole and 5-amino-4-cyano-1- (4-chloro-2-methylphenyl)pyrazole are new compounds. Herbicidal compositions containing such N-phenylpyrazole derivatives are described and also processes for the preparation of the new compounds.
Patent ES-506895-A0 (ES)
IPC: A61K31/40
Filed: 1981-11-05
Abstract: An antibacterial composition comprising (a) cephaloridine and a 3-substituted propenoate of either of the formula <CHEM> wherein e.g. R<2> and R<3> are hydrocarbon radicals; a terminal hydrogen in R<3> can be replaced by several groups; R<1> is hydrogen or C1-C6 alkyl or dialkylaminoalkyl, n is 3 to 5 and Y is heterocyclic or phenyl optionally substituted with hydroxyl, oxo, carboxyl, or methyl or (b) thienamycin, N-guanyl or N-formimidoyl thienamycin and a compound of formula II. The propenoate compounds prevent nephrotoxicity of the antibiotics. The antibiotic to propenoate weight ratio is from about 1 to 0.1-3.
Patent ES-515987-A0 (ES)
IPC: G01N33/92
Filed: 1982-09-27
Abstract: 1. Process for selectively precipitating low density lipoproteins in biological liquids or tissue extracts, without precipitating, as the case may be, high density lipoproteins, by a reagent comprising one or more polyanions such as heparin, polyethylene glycols, phosphotungstic acid, a dextrane sulphate, associated or not associated with divalent cations, characterized in that, in order to prevent the concomitant precipitation of very low density lipoproteins and/or of chylomicrons, a reagent comprising in combination with the above elements an anionic, a cationic or non ionic detergent is used, said detergent being other than a polyethylene glycol when the reagent containing one or more polyanions is a polyethylene glycol.
Patent ES-520301-A0 (ES)
IPC: A01N43/64
Filed: 1983-03-04
Abstract: Fungicidally active novel substituted azolylethyl oximinoalkyl ethers of the formula   <IMAGE>   in which A is a nitrogen atom or the CH group, R1 is optionally substituted phenyl, R2, R3 and R4 each independently is hydrogen, alkyl or optionally substituted phenyl, and R5 is hydrogen, alkyl, alkenyl, alkinyl, optionally substituted phenyl or optionally substituted phenylalkyl, or addition products thereof with acids or metal salts.
Patent ES-532147-A0 (ES)
IPC: C07D401/12
Filed: 1984-05-03
Abstract: The invention relates to the use of 1-H-imidazol-1-ethanol and compounds of the formula 
<CHEM>
 in which R represents an organic acid residue which does not bear further carboxyl groups, either in the free or salt form, as sebum synthesis inhibitors. 
<??>The invention also relates to parmaceutical preparations comprising a compound of formula I, and their preparation and to the compounds of formula I in which R is as defined above except the acetic acid residue, and their preparation.
Patent ES-535374-A0 (ES)
IPC: A23F5/24
Filed: 1984-08-23
Abstract: Mixtures of substances containing organic components are segregated by extraction with a gaseous solvent in high pressure extraction. One additive component is admixed to the charged solvent, whereby the solvent capacity of the solvent is strongly reduced and consequently a precipitation is achieved for at least a portion of the components to be captured as an extract.
Patent ES-538437-A0 (ES)
IPC: E01F9/70
Filed: 1984-12-10
Abstract: The object of this invention is a machine which automatically collects hollow conical road markers, stores them, transports them and dispenses them in a line. This machine is comprised of a vehicle carrying a series of vertical cylindrical magazines open at both ends which are supported by a vertical central shaft which rotates them stepwise (into position). The machine includes a device which collects the cone markers comprised of a chain elevator having projections each of which penetrates one cone marker. When the chain reaches the top, the cone marker is released into the top of the magazine where they pile up one on top of the other.
Patent ES-539938-A0 (ES)
IPC: C08J5/04
Filed: 1985-01-29
Abstract: This invention relates to a process to produce resin matrix materials. More particularly, it relates to an improved method to prepare resin-reinforced fiber composites, such as sheets and tapes, and their consolidation under heat and pressure into laminates.
Patent ES-543332-A0 (ES)
IPC: B41M5/155
Filed: 1985-05-21
Abstract: A colour developer composition for use in record material for pressure-sensitive record material comprises a zinc-modified addition product of phenol and a diolefinic alkylated or alkenylated cyclic hydrocarbon.
Patent ES-551963-A0 (ES)
IPC: C07C51/16
Filed: 1986-02-13
Abstract: Novel biologically-active tetracyclic spirohydantoin derivatives of formula 
<CHEM>
 wherein
 X is hydrogen, fluorine, chlorine or methyl; and
 R is hydrogen, alkyl, alkenyl, cycloalkyl, benzyl, 4-hydroxybenzyl, pyridyl, HSCH2-, CH3SCH2-, CH3SCH2CH2-, FCH2-, HOCH2-, CH2CH(OH)-, CH3CH(OH)CH2-, HOOCCH2-, HOOCCH2CH2-, H2NCOCH2-, H2NCOCH2CH2-, H2NCH2CH2- CH2CH2-, 

H2@@@H-CH2CH2CH2-, 
<CHEM>
 COOC2H5, -CONH2, CONH(CH2)2OH, -CONH cyclohexyl, -CONH-nBu, -CONH(CH2)3 N(CH3)2, -CON(C2H5)2, 
<CHEM>
 phenyl or phenyl substituted by chlorine, fluorine, bromine, hydroxy, methyl, methoxy, trifluoromethyl, -COCH3, -N(CH3)2, -SCH3, -SOCH3, -SO2CH3, -COOH, -CONH2, -COOCH3 or -CON Alk, are disclosed. 
<??>These derivatives are potent inhibitors of aldose reductase and useful in treating diabetic complications are disclosed. Pharmaceutical compositions containing the novel compounds and a method of treating chronic diabetic complications are also disclosed.
Patent ES-554679-A0 (ES)
IPC: C12Q1/28
Filed: 1986-05-06
Abstract: Method for detecting the presence of periodontal disease by contacting saliva from a patient suspected of having said disease condition with hydrogen peroxide and a buffered aqueous solution of 4-aminoantipyrine and a phenolic component and observing the color produced as an indication of the presence of periodontal disease, said phenolic component being (i) sodium 2-hydroxy-3,5-dichlorobenzene sulfonate; (ii) p-hydroxybenzoic acid; (iii) p-methoxyphenol; or (iv) 2,6-dichlorophenol.
Patent ES-555593-A0 (ES)
IPC: C08F299/02
Filed: 1986-06-02
Abstract: The present invention is a low styrene emission, VER composition containing: (1) a VER which is an esterification product of a polyepoxide and a monounsaturated monocarboxylic acid; (2) styrene as a reactive diluent; (3) paraffin as a styrene emission inhibitor; and (4) a drying oil as an adhesion promoter for fiber-reinforced application. The drying oil is present in an amount sufficient to increase the adhesion characteristics of the VER composition with a reinforcing material used therewith. The composition of this invention is useful in fabricating a range of fiber-reinforced plastic structures and equipment.
Patent FI-830630-A0 (FI)
Inventor: REICHEN FREDY
IPC: F16L27/00
Filed: 1983-02-25
Abstract: Two rigid cylindrical sleeves are interconnected by a spring bellows. Each cylindrical sleeve carries a flange section. Such flange section is provided with joint plates. The joint plates are a forklike interconnecting structure. A rolling contact wedge member is located in a first number of joint plates and a rolling contact prism member is located in a second number of joint plates. This provides for a hinge-like joint of a rolling contact rocker structure having a line contact only of the parts moving relative to each other. Because no friction exists in such hinge joint, a cold welding is not possible. Accordingly, no additional stresses due to such cold welding will be able to exist in the pipe conduit sections interconnected by this apparatus.
Patent FI-841385-A0 (FI)
Inventor: SUOMINEN SEPPO KALERVO
IPC: B65G1/00
Filed: 1984-04-09
Abstract: PCT No. PCT/FI85/00038 Sec. 371 Date Dec. 4, 1985 Sec. 102(e) Date Dec. 4, 1985 PCT Filed Apr. 9, 1985 PCT Pub. No. WO85/04638 PCT Pub. Date Oct. 24, 1985.A computer-controlled storage system for handling and storing goods items, comprising at least one horizontal storage line provided with rails or equivalent guide members and one or more transport carriages (6) movable along the rails. The system comprises a transport apparatus comprising a power unit (16) with a power transmission mechanism (17) and a rope member (18), connecting these to the transport carriage (6), external to the transport carriage. In addition, the system may comprise a power transmission arrangement connected to the lifting member, external to the transport carriage (6), for lifting a goods item in position above the transport carriage off the guide member to be carried by the transport carriage and for lowering same onto the guide member.
Patent FI-861405-A0 (FI)
Inventor: KIESEWETTER REINHOLD
IPC: H01H13/52
Filed: 1986-04-01
Abstract: The invention relates to a keycap for a control unit of a telephone device, in which the keyboard is arranged inside the housing and can be pressed by means of a peg connected to the key cap for operation. The keycap, inserted in a housing opening, is provided with one or more pointed spring elements (2) on the side, which run downwards at an acute angle and are supported on a light conductor (7) in whose hole the peg (5) is inserted. Light is directed via the light conductor and peg to the characters and symbols which consist of a light-collecting plastic. Such a keycap is described in more detail in the main patent. The invention proposes a three layer construction of the keycap, the base body (4, 5) provided with the peg consisting of a clear-glass material, onto which a relatively thin layer (11) is applied with elevated symbols and around which, once again, there is fixedly arranged an opaque layer (12) with spring elements (2). <IMAGE>
Patent FI-863660-A0 (FI)
Inventor: STRONG JERRY GLENN
IPC: C04B28/34
Filed: 1986-09-10
Abstract: An aqueous aluminum phosphate solution, comprising component (i) mono aluminum tris(dihydrogen phosphate) and component (ii) a salt of a metal selected from the group consisting of alkali metals, alkaline earth metals and aluminum and mixtures thereof, and an acid at least as strong as phosphoric acid, with the proviso that if the said metal consists of aluminum, then said acid is stronger than phosphoric acid and (iii) phosphoric acid. The phosphate solution is used to react with a metal oxide curing agent in the presence of an aggregate to form a set cement.
Patent FI-875732-A0 (FI)
Inventor: MASSEY RICHARD J
IPC: C07K16/00
Filed: 1987-12-28
Abstract: Novel compounds for use in electrochemiluminescent assays and characterised by containing the structure        X - Y - ZwhereinX represents one or more nucleotides which may be the same or different, one or more amino acids which may be the same or different, an antibody, an analyte of interest or an analogue of an analyte of interestY represents a linker group attached to X and Z,andZ represents an electrochemiluminescent moiety, and intermediates employed in their synthesis.
Patent FI-882605-A0 (FI)
Inventor: PAQUES ERIC PAUL
IPC: A61P7/02
Filed: 1988-06-02
Abstract: On preparation of parenteral solutions for the treatment and prophylaxis of thromboses and embolisms to date it has been necessary, because of the poor solubility of t-PA, either to infuse very large volumes or else prepare a solution with a low volume and high t-PA concentration by adjusting to a low, non-physiological pH of 2 to 5. The invention therefore relates to a process for preparing a solution of high specific volume-based activity of a protein with plasminogen activator activity, achieving an increase in stability and solubility by adding at least two substances from the group of D-and/or L-amino acids, the salts, derivatives or homologues thereof, and to a process for pasteurising a protein solution with t-PA activity and to the use of this solution as fibrinolytic in human and veterinary medicine.
Patent FI-883402-A0 (FI)
Inventor: SHIOKAWA YOUICHI
IPC: C07D277/30
Filed: 1988-07-18
Abstract: A compound of the formula : <CHEM> wherein R<1> is hydrogen, lower alkyl, halo(lower)alkyl, halogen, aryl which may have suitable substituent(s), heterocyclic group, amino which may be substituted by suitable substituent(s) or N,N-di(lower)alkylamino(lower)alkyl,  R<2> is hydrogen, lower alkyl or N-[nitrooxy(lower)alkyl]carbamoyl,  X is -O- or -S-,  Y is a single bond, lower alkylene or lower alkenylene, and Z is lower alkylene which may be substituted by suitable substituent(s) or lower alkyleneoxy(lower)alkylene, and pharmaceutically acceptable salts thereof, which have vasodilating activities, to process for the preparation thereof, and to a pharmaceutical composition comprising the same for therapeutical treatment of cardiovascular disorder in human being.
Patent FI-910391-A0 (FI)
Inventor: DENNEMAN JAN WILLEM
IPC: H05B41/392
Filed: 1991-01-25
Abstract: The invention relates to a circuit arrangement suitable for operating a low-pressure mercury discharge lamp (IV) by means of a high-frequency pulsatory current, comprising   circuitry (I) for generating the high-frequency pulsatory current with an amplitude A from a supply voltage, a modulator (II) for modulation into a substantially square-wave shape of the high-frequency pulsatory current with a modulation frequency f and a duty cycle DC.   According to the invention, the circuit arrangement is further provided with     circuitry for adjusting the modulation frequency f.   It is possible with the latter circuitry to adjust the colour point of the lamp over a considerable range while the luminous flux remains practically constant. <IMAGE>
Patent FI-912653-A0 (FI)
Inventor: PENTECOST MARK ALFRED JAMES
IPC: B29C48/10
Filed: 1991-06-03
Abstract: PCT No. PCT/AT89/00117 Sec. 371 Date Jun. 5, 1991 Sec. 102(e) Date Jun. 5, 1991 PCT Filed Dec. 6, 1989 PCT Pub. No. WO90/06218 PCT Pub. Date Jun. 14, 1990.A shaped part comprises a body of plastic material, more than 50% of the volume of the shaped part consisting of plastic waste particles and particles of impurity distributed therethrough and embedded therein. The plastic waste particles have a flow point or more than 80 DEG  C. and a length of less than 6 mm, up to 70% of the volume of the shaped part comprising plastic waste particles having a flow point exceeding the maximum processing temperature of the plastic material of the body. A portion of the plastic waste particles have a wall thickness of more than 0.5 mm and the remaining portion thereof has a wall thickness of less than 0.5 mm. Particles of the plastic material, plastic waste and impurities are mixed, the plastic material particles are plasticized at a processing temperature of 150 DEG  C. to 210 DEG  C. while the mixture is subjected to a spiral movement and the pressure is increased to obtain a melt, of the plastic material wherein the plastic waste and impurities are substantially uniformly distributed and embedded, and the melt is shaped.
Patent FI-925453-A0 (FI)
Inventor: BJURSELL GUNNAR
IPC: C12N9/20
Filed: 1992-11-30
Abstract: Bile-salt stimulated lipase (BSSL) may comprise amino acids 1-722, 1-535, 1-278, 1-341, 1-409, 1-474, 279-341, 279-409, 279-474, 342-409, 342-474 or 536-722 of the sequence given at the end. Also claimed are (1) a functionally equivalent variant or mutant of BSSL; (2) a DNA sequence (I) encloding BSSL, comprising nucleotides 151-2316, 151-1755, 151-985, 151-1172, 151-1376, 151-1574, 986-1172, 986-1376, 986-1574, 1173-1376 or 1173-1574 of the sequence given in the specification; (3) a vector comprising (I); and (4) a host organism transformed with the vector of (3); and (5) an infant food formulation comprising BSSL. Pref. BSSL may be in combination with one or more of the direct repeats of the sequence given in the specification. BSSL may posses Met as additional N-terminal amino acid.
Patent FI-933584-A0 (FI)
Inventor: HERNVALL HANS
IPC: F16L11/08
Filed: 1993-08-13
Abstract: A hose (24) constitutes a part of a milking machine and has an end portion (30) which is radially expanded and applied on a tubular nipple (29), the outer diameter of which exceeds the inner diameter of the hose. The milking machine comprises means for providing a negative pressure in the hose. The hose is reinforced by means of at least one elongated reinforcement member (25, 26), which consists of a material substantially harder than the wall of the hose and which extends along the hose in a helical cavity in the wall of the hose. In addition, the reinforcement member completely fills up said cavity and is arranged therein, such that relative movement between the reinforcement member and the wall of the hose is allowed.
Patent FI-934004-A0 (FI)
Inventor: PHILLIPS Thomas
IPC: C07D405/04
Filed: 1993-09-13
Abstract: The invention relates to novel quinolone and naphthyridone derivatives which are substituted in the 7-position by a partially hydrogenated isoindolinyl ring, processes for their preparation and antibacterial compositions and feed additives containing these compounds.
Patent FI-942691-A0 (FI)
Inventor: GOUKA ROBERTUS JOHANNES
IPC: C12R1/665
Filed: 1994-06-08
Abstract: PCT No. PCT/EP92/02896 Sec. 371 Date Jun. 7, 1994 Sec. 102(e) Date Jun. 7, 1994 PCT Filed Dec. 9, 1992 PCT Pub. No. WO93/12237 PCT Pub. Date Jun. 24, 1993Methods are described for the isolation and characterization of DNA sequences from Aspergillus niger var. awamori which are involved in the expression and secretion of endoxylanase II (exlA) by said Aspergillus mould. A process using these expression and/or secretion regulating regions to direct the production and optionally the secretion of proteins other than endoxylanase II by transformed moulds is provided.
Patent FI-943205-A0 (FI)
Inventor: IGARI YASUTAKA
IPC: A61K9/16
Filed: 1994-07-05
Abstract: A method of producing a sustained-release preparation which includes permitting a water-soluble polypeptide to permeate into a biodegradable matrix in the aqueous solution. The production method of the present invention makes possible the permeation of a water-soluble polypeptide into a biodegradable matrix without bringing the water-soluble polypeptide into contact with an organic solvent. Hence the water-soluble polypeptide is prepared without affecting the water-soluble polypeptide bioactivity and is thus effective for use as a pharmaceutical.
Patent FI-944629-A0 (FI)
Inventor: INOUE FUJIO
IPC: B65D65/40
Filed: 1994-10-04
Abstract: A multilayered medical film mainly used for forming a double-compartment medical container and excellent in heat resistance, transparency, flexibility, impact resistance, and easiness in peeling and sealing, which film is composed of: an inner layer formed from a resin mixture composed of an ethylene/ alpha -olefin copolymer having a density of 0.930-0.945 g/cm<3> and polypropylene, an intermediate layer containing at least one mixed resin layer formed from a resin mixture, in a ratio of 1:5 to 2:1 by weight, of an ethylene/ alpha -olefin copolymer having a density of 0.920-0.945 g/cm<3> and an ethylene/ alpha -olefin elastomer having a density of 0.880-0.890 g/cm<3>, wherein the mixed resin layer accounts for at least 85 % of the whole intermediate layer in thickness, and an outer layer formed from an ethylene/ alpha -olefin copolymer having a density of 0.930-0.945 g/cm<3>. <IMAGE>
Patent FI-945526-A0 (FI)
Inventor: HALLIKAINEN KEIJO
IPC: B60T17/02
Filed: 1994-11-24
Abstract: A method of controlling a fluid compression system having at least one compressor for compressing a fluid medium includes defining the permissible minimum and maximum values of the user line pressure at the point of demand. The user line pressure is continuously monitored using a pressure sensor, and the working pressure of the compressor is monitored. The pressure difference between the working pressure of the compressor and the user line pressure at the point of demand is monitored. The pressure rate-of-change of the fluid medium delivered to the point of demand is monitored, and at least one of the compressors is controlled by a control unit on the basis of at least one of the monitored parameters defined in the foregoing steps of the method. A control system for controlling the operation of at least one compressor uses a plurality of sensors for sensing the status of the flowing medium.
Patent FI-945674-A0 (FI)
Inventor: CAMPBELL ALEXANDER CUPPLES
IPC: C07J31/00
Filed: 1994-12-01
Abstract: The invention is related to substituted 2 beta -morpholino-androstane derivatives, bonded at their 2 beta -position to the nitrogen of a group of formula I   <IMAGE>   wherein R represents one to four substituents, each one independently selected from (1-4C) alkyl, phenyl and benzyl, or two at the same carbon atom being together -(CH2)n- wherein n is 2-6; and Y is O or S, or a pharmaceutically acceptable salt thereof. These steroids are very potent intravenous anaesthetics. The compounds have fast onset times and ideal 'sleep duration' vs. 'recovery to full coordination' profiles.
Patent FI-945740-A0 (FI)
Inventor: OEHMAN CLIFFORD
IPC: E01C13/00
Filed: 1994-12-07
Abstract: Slide for sport and play, the exposed surface of which is built up from a melted mixture comprising a natural and/or synthetic hard wax, a polymer, a mineral and optionally a friction and wear reducing additive.
Patent FI-954553-A0 (FI)
Inventor: MOTTE PHILIPPE
IPC: C08G18/63
Filed: 1995-09-26
Abstract: A polyol blend for use in production of a high resilience foam is described. The blend comprises: a reactive polymer polyol of the kind used in high resilience polyurethane foam; a polyol of the kind used in conventional polyurethane foam; and a diol as a chain extender. A composition of the polyol blend and a silicone surfactant may be reacted with a modified toluene diisocyanate to produce a high resilience polyurethane foam.
Patent FI-955507-A0 (FI)
Inventor: MIECZKOWSKA JOLA E
IPC: H01M4/62
Filed: 1995-11-15
Abstract: The invention relates to primary alkaline cells containing manganese dioxide cathode active material. Anatase titanium dioxide is added to the manganese dioxide cathode material resulting in an increase in the useful service life of the cell. Typically the anatase titanium dioxide comprises between 0.1 and 5 percent by weight of the cathode active material.
Patent FI-961950-A0 (FI)
Inventor: SIEBENWURST ROBERT
IPC: F04C19/00
Filed: 1996-05-08
Abstract: The machine has a machine housing (1) with a circular inner cross-section, closed by end plates (2) at each axial end. At least one of the shields has a control disc (3), for eccentrically supporting a rotor wheel (5) relative to the inner contour of the machine housing. The machine housing can pivot about a point offset from the machine axis (8) relative to the end plate or control disc, to alter its position relative to the rotor wheel, for optimising the machine operation by adjusting the required pivot position.
Patent AP-9901725-A0 (AP)
Title: Novel process for manufacturing paroxetine solid dispersions.
Inventor: KRAPE PHILLIP J
IPC: A61K9/10
Filed: 1998-06-26
Abstract: Solid dispersions of poorly soluble drugs are disclosed which are prepared using a solvent or fusion process. Such dispersions are manufactured with the free base of the drug, specifically paroxetine free base, an oil, allowing for a low temperature for the fusion process, decreased organic solvent volumes for the solvent process and the formation of a paroxetine salt during the solid dispersion manufacture process.